Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant: Stat News

This post was originally published on this site

NEW JERSEY (REUTERS) – Johnson & Johnson’s Covid-19 vaccine study has been paused due to an unexplained illness in a study participant, Stat News reported on Monday (Oct 12), citing a document obtained by the news organisation.

A document sent to outside researchers running the 60,000-patient clinical trial states that a “pausing rule” has been met, the online system used to enroll patients in the study has been closed and the data and safety monitoring board would be convened, the report said.

The company did not immediately respond to a Reuters request for comment.

Related Stories: 

Bastion Balance Seoul.